FDA Infertility Trial Endpoints: Committee Says Don’t Count Your Eggs
Executive Summary
Infertility drug trials should use clinical pregnancy as a primary endpoint, as defined by the presence of a fetal heart beat and gestational sac, FDA's Reproductive Health Drugs Advisory Committee members agreed Sept. 29